Vaxcyte (PCVX) Competitors $30.10 +0.99 (+3.38%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PCVX vs. TEVA, ITCI, SMMT, GMAB, RDY, MRNA, VTRS, QGEN, ASND, and ROIVShould you be buying Vaxcyte stock or one of its competitors? The main competitors of Vaxcyte include Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Viatris (VTRS), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Vaxcyte vs. Teva Pharmaceutical Industries Intra-Cellular Therapies Summit Therapeutics Genmab A/S Dr. Reddy's Laboratories Moderna Viatris Qiagen Ascendis Pharma A/S Roivant Sciences Vaxcyte (NASDAQ:PCVX) and Teva Pharmaceutical Industries (NYSE:TEVA) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations. Do analysts prefer PCVX or TEVA? Vaxcyte presently has a consensus target price of $136.50, suggesting a potential upside of 358.19%. Teva Pharmaceutical Industries has a consensus target price of $23.43, suggesting a potential upside of 71.95%. Given Vaxcyte's stronger consensus rating and higher possible upside, equities analysts clearly believe Vaxcyte is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaxcyte 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10Teva Pharmaceutical Industries 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Is PCVX or TEVA more profitable? Vaxcyte has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Vaxcyte's return on equity.Company Net Margins Return on Equity Return on Assets VaxcyteN/A -23.53% -22.20% Teva Pharmaceutical Industries -9.91%42.46%6.65% Do insiders & institutionals have more ownership in PCVX or TEVA? 96.8% of Vaxcyte shares are held by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 3.1% of Vaxcyte shares are held by company insiders. Comparatively, 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PCVX or TEVA? Teva Pharmaceutical Industries received 1280 more outperform votes than Vaxcyte when rated by MarketBeat users. However, 78.26% of users gave Vaxcyte an outperform vote while only 67.82% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformVaxcyteOutperform Votes5478.26% Underperform Votes1521.74% Teva Pharmaceutical IndustriesOutperform Votes133467.82% Underperform Votes63332.18% Which has better valuation & earnings, PCVX or TEVA? Vaxcyte has higher earnings, but lower revenue than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Vaxcyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaxcyteN/AN/A-$402.27M-$3.80-7.84Teva Pharmaceutical Industries$16.54B0.93-$1.64B-$1.45-9.40 Does the media prefer PCVX or TEVA? In the previous week, Teva Pharmaceutical Industries had 8 more articles in the media than Vaxcyte. MarketBeat recorded 20 mentions for Teva Pharmaceutical Industries and 12 mentions for Vaxcyte. Teva Pharmaceutical Industries' average media sentiment score of 1.18 beat Vaxcyte's score of 1.01 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vaxcyte 9 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Teva Pharmaceutical Industries 15 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, PCVX or TEVA? Vaxcyte has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. SummaryVaxcyte beats Teva Pharmaceutical Industries on 11 of the 18 factors compared between the two stocks. Remove Ads Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCVX vs. The Competition Export to ExcelMetricVaxcyteBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.82B$2.83B$5.30B$7.37BDividend YieldN/A1.90%5.11%4.31%P/E Ratio-6.4630.4521.6917.76Price / SalesN/A437.32377.9494.24Price / CashN/A168.6838.1534.64Price / Book2.283.436.413.98Net Income-$402.27M-$72.06M$3.20B$247.41M7 Day Performance6.24%5.39%4.61%4.22%1 Month Performance-60.40%-18.17%-9.97%-7.89%1 Year Performance-52.28%-28.27%10.75%1.25% Vaxcyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCVXVaxcyte3.2666 of 5 stars$30.11+3.4%$136.50+353.4%-53.2%$3.88BN/A-6.55160Positive NewsTEVATeva Pharmaceutical Industries3.0428 of 5 stars$13.91+0.8%$23.43+68.5%+2.4%$15.77B$16.54B-9.5936,800Analyst DowngradeOptions VolumePositive NewsITCIIntra-Cellular Therapies3.4454 of 5 stars$131.87flat$106.23-19.4%N/A$14.05B$680.50M-151.57560Positive NewsSMMTSummit Therapeutics2.4632 of 5 stars$17.32-0.2%$35.40+104.4%+551.1%$12.78B$700,000.00-61.85110Gap DownGMABGenmab A/S4.2127 of 5 stars$18.19-1.1%$41.33+127.2%-33.6%$12.04B$21.53B10.451,660Short Interest ↓Analyst RevisionGap DownHigh Trading VolumeRDYDr. Reddy's Laboratories2.2332 of 5 stars$12.59+1.8%$17.00+35.1%-6.3%$10.51B$311.31B20.0424,800Positive NewsHigh Trading VolumeMRNAModerna4.2421 of 5 stars$25.64+2.1%$59.00+130.1%-75.7%$9.91B$3.20B-2.763,900Analyst ForecastVTRSViatris2.9827 of 5 stars$7.61-0.1%$10.50+38.0%-33.5%$9.08B$14.74B-10.2837,000High Trading VolumeQGENQiagen3.3853 of 5 stars$40.33+5.4%$47.71+18.3%+8.4%$8.96B$1.98B112.296,030High Trading VolumeASNDAscendis Pharma A/S3.0645 of 5 stars$140.14-1.8%$204.64+46.0%+11.8%$8.50B$363.64M-19.741,017Analyst ForecastPositive NewsROIVRoivant Sciences2.6416 of 5 stars$9.26-2.1%$17.50+89.0%-6.4%$6.61B$122.59M-61.73860Positive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Teva Pharmaceutical Industries Competitors Intra-Cellular Therapies Competitors Summit Therapeutics Competitors Genmab A/S Competitors Dr. Reddy's Laboratories Competitors Moderna Competitors Viatris Competitors Qiagen Competitors Ascendis Pharma A/S Competitors Roivant Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCVX) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PCVX Stock Free PCVX Stock Alerts